{"meta":{"query_hash":"68e65a716cf1","filters":{"venue":"European Cardiology Review"},"cohort_total":21,"direct_labels_cover":0,"predictions_cover":21,"exported":21,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/68e65a716cf1","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Cardiology+Review"},"results":[{"id":"W1977315639","doi":"10.15420/ecr.2007.0.1.54","title":"Contrast-induced Nephropathy in Coronary Intervention","year":2007,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Contrast-induced nephropathy; Medicine; Creatinine; Dialysis; Nephropathy; Cardiology; Internal medicine; Contrast (vision); Urology; Endocrinology; Computer science","score_opus":0.042652818850022436,"score_gpt":0.36468556908585975,"score_spread":0.32203275023583733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977315639","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37624556,0.23081627,0.0013054087,0.004473285,0.00090449065,0.0033496802,0.00003591525,0.00024920868,0.3826202],"genre_scores_gemma":[0.9669288,0.025883952,0.0001177128,0.00572406,0.00041197438,0.000019480522,0.00011461113,0.000049646675,0.0007497795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99735206,0.0010769661,0.0006205981,0.00033865927,0.00018196391,0.00042974885],"domain_scores_gemma":[0.9990393,0.00010014786,0.00009281814,0.000457716,0.000103429724,0.00020662553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051489393,0.0001661963,0.00072995556,0.00013664935,0.000029860887,0.0000042564648,0.00017250906,0.000060324535,0.00026685573],"category_scores_gemma":[0.0007397345,0.00013738438,0.00028299808,0.0002869199,0.00009714529,0.000051592888,0.0001264571,0.00052872923,0.0012090357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007109539,0.00021125542,0.15055199,0.003477972,0.0003806502,0.021974988,0.000084367864,8.927869e-8,0.010021707,0.0002460638,0.15479504,0.6575449],"study_design_scores_gemma":[0.0022285306,0.0007805064,0.6058456,0.0035628958,0.0001603237,0.0029858681,0.000035325986,0.0000022241625,0.00011528654,0.0000075070225,0.3840997,0.00017627778],"about_ca_topic_score_codex":0.000004493634,"about_ca_topic_score_gemma":0.0000021798005,"teacher_disagreement_score":0.65736866,"about_ca_system_score_codex":0.00010757876,"about_ca_system_score_gemma":0.00004999921,"threshold_uncertainty_score":0.99956864},"labels":[],"label_agreement":null},{"id":"W2315738213","doi":"10.15420/ecr.2010.6.1.15","title":"Radiation Minimisation and Outcome Maximisation in Cardiac Computed Tomograpy","year":2010,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Radiation dose; Medical physics; Medicine; Radiation exposure; Computed tomography; Minimisation (clinical trials); Reduction (mathematics); Computer science; Radiology; Risk analysis (engineering); Nuclear medicine; Mathematics","score_opus":0.021520513829933176,"score_gpt":0.30233054105351675,"score_spread":0.28081002722358356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315738213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88170636,0.073450625,0.00044651766,0.009394974,0.0013170175,0.0015815784,0.000009300704,0.00016807305,0.03192554],"genre_scores_gemma":[0.9623661,0.032823514,0.00048768715,0.003595892,0.0004532557,0.000012150971,0.00014894977,0.000023410988,0.000089061825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872065,0.00042526604,0.00039458403,0.00023720528,0.00008696431,0.000135358],"domain_scores_gemma":[0.99947596,0.00006013643,0.00010570227,0.00024346802,0.000039883726,0.000074831674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012024277,0.00011433133,0.0004847264,0.0001240141,0.000034946872,0.000010898027,0.00004829291,0.000042165328,0.000024398369],"category_scores_gemma":[0.00027585696,0.00010252325,0.000109011475,0.00019466685,0.000051870942,0.00009058136,0.00002032926,0.0002510919,0.00007539239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075639277,0.000008762255,0.6847917,0.00033369297,0.000039093593,0.000028720542,0.00007341116,0.0000031895888,0.0011911788,0.00009208474,0.003440943,0.3099897],"study_design_scores_gemma":[0.00047299932,0.00002858097,0.83031344,0.00017810932,0.00008627474,0.000093141374,0.0000059158156,0.00008571472,0.000027494245,0.0000066242746,0.16861473,0.000086967724],"about_ca_topic_score_codex":0.000004406539,"about_ca_topic_score_gemma":6.3415524e-7,"teacher_disagreement_score":0.30990273,"about_ca_system_score_codex":0.000019840068,"about_ca_system_score_gemma":0.00002048628,"threshold_uncertainty_score":0.41807768},"labels":[],"label_agreement":null},{"id":"W2328942685","doi":"10.15420/ecr.2012.8.3.174","title":"Clinical Implications from Recent Trials and New Guidelines for Stroke Prevention in Atrial Fibrillation","year":2012,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Cardiovascular Society","funders":"","keywords":"Medicine; Atrial fibrillation; Rivaroxaban; Apixaban; Stroke (engine); Internal medicine; Antithrombotic; Cardiology; Clinical trial; Dabigatran; Heart Rhythm; Intensive care medicine; Heart failure; Warfarin","score_opus":0.5875443604694295,"score_gpt":0.5373980323582584,"score_spread":0.050146328111171035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328942685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018539868,0.84925723,0.016924981,0.09872144,0.0027689936,0.007610885,0.000083613195,0.0001399963,0.0059530116],"genre_scores_gemma":[0.01835796,0.91923285,0.016836375,0.002397718,0.040019225,0.000007300317,0.00081019563,0.00004943488,0.002288938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967137,0.0013994289,0.0014066658,0.00024305332,0.0000719263,0.00016523628],"domain_scores_gemma":[0.99833125,0.00079560064,0.0003647615,0.00026123715,0.00012487757,0.0001222466],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0065577924,0.00012378028,0.0011003235,0.000055218014,0.00003482755,0.000007850888,0.000046264453,0.000061761544,0.00005591761],"category_scores_gemma":[0.0088285785,0.00009549051,0.00058137067,0.000102168364,0.000024477218,0.000083420186,0.000054191376,0.00007187189,0.0000559651],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112435875,0.0000011230435,0.3891735,0.00010290723,0.00017785668,3.998034e-7,0.0000059949716,0.000005029345,0.000023556287,0.00028880042,0.033782426,0.57632595],"study_design_scores_gemma":[0.0015569228,0.000059752143,0.33412117,0.00027571563,0.0006955725,0.0000048690367,0.0000026863477,0.0000043607038,6.561207e-7,0.00017483461,0.66303986,0.00006360767],"about_ca_topic_score_codex":0.000004141285,"about_ca_topic_score_gemma":0.0000014774914,"teacher_disagreement_score":0.62925744,"about_ca_system_score_codex":0.00002161849,"about_ca_system_score_gemma":0.000041563173,"threshold_uncertainty_score":0.9995205},"labels":[],"label_agreement":null},{"id":"W2329310499","doi":"10.15420/ecr.2011.7.1.29","title":"Emerging Cardiac Resynchronisation Therapy Indications","year":2011,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiogenic shock; Cardiology; Ejection fraction; Internal medicine; QRS complex; Sinus rhythm; Atrial fibrillation; Ambulatory; Myocardial infarction","score_opus":0.08928142929447073,"score_gpt":0.3233920647653151,"score_spread":0.23411063547084437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329310499","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077353143,0.2920808,0.00032286826,0.0003071877,0.00029599198,0.0003864034,0.0000062589943,0.00014262987,0.69872254],"genre_scores_gemma":[0.6221573,0.37459332,0.00035862322,0.0016740725,0.0005559984,0.000025026964,0.0000464294,0.000034982455,0.00055425335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855447,0.0005822316,0.0003126464,0.0002589711,0.00011908978,0.00017256559],"domain_scores_gemma":[0.99919623,0.000042459997,0.00011038981,0.00046232354,0.000113199785,0.000075423006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008595539,0.00013735607,0.0006837501,0.000070697504,0.00012436896,0.00000380843,0.000027811768,0.000029560677,0.000053180534],"category_scores_gemma":[0.00016260352,0.00010965125,0.00038391727,0.00020581654,0.00009920622,0.00003559885,0.000042990596,0.00012432486,0.0007421164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098093566,0.00005177067,0.33166093,0.0012662606,0.0028508117,0.00014410802,0.002548315,0.0000034342067,0.0008050926,0.0017571851,0.30902955,0.34978446],"study_design_scores_gemma":[0.00020495744,0.000061844265,0.27426732,0.00041278466,0.00021468049,0.00022441705,0.000039168222,1.4742022e-7,0.000023668033,0.000012652432,0.72443616,0.000102203136],"about_ca_topic_score_codex":0.000004346753,"about_ca_topic_score_gemma":6.444698e-8,"teacher_disagreement_score":0.69816834,"about_ca_system_score_codex":0.000032746917,"about_ca_system_score_gemma":0.000040123014,"threshold_uncertainty_score":0.9538653},"labels":[],"label_agreement":null},{"id":"W2334598944","doi":"10.15420/ecr.2007.0.1.16","title":"European Physicians’ Perspectives on Cholesterol Management and Inhibition of Cholesterol Absorption and Production","year":2007,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Universiteit van Amsterdam","keywords":"Coronary heart disease; Medicine; Clinical trial; Cholesterol lowering; Cholesterol; Intensive care medicine; Disease management; Ldl cholesterol; Production (economics); Disease; Environmental health; Internal medicine","score_opus":0.01670079675108503,"score_gpt":0.26452341732641454,"score_spread":0.2478226205753295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334598944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8756659,0.080141686,0.0006752675,0.0010242097,0.00014498542,0.0016070608,0.0000032586686,0.00006564611,0.040671956],"genre_scores_gemma":[0.88267505,0.11544335,0.00014043205,0.0009732511,0.0005629144,0.0000064960086,0.000015221055,0.000032710737,0.00015054482],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982332,0.00064629846,0.00033560605,0.00043426832,0.00017575514,0.00017487143],"domain_scores_gemma":[0.99926853,0.000008970678,0.00013998999,0.0004325162,0.000078004865,0.00007195942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002838977,0.00015991511,0.00050373655,0.00007408785,0.000057401016,0.000006290424,0.000033569384,0.000024338375,0.0000021890864],"category_scores_gemma":[0.00004038166,0.00013234952,0.00014632815,0.00012197634,0.00013577423,0.000056962774,0.000054014814,0.00017717217,0.000029401883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106225474,0.00010103168,0.0034570177,0.0084961625,0.00041693746,0.00020046557,0.0006456288,0.0000030277251,0.0030691733,0.00030203265,0.0008218021,0.9823805],"study_design_scores_gemma":[0.0010912339,0.00051551906,0.9607025,0.0054705944,0.00053727545,0.0005615667,0.00037856205,3.831564e-7,0.00030174686,0.0000072963985,0.030274164,0.00015919963],"about_ca_topic_score_codex":0.0000020216896,"about_ca_topic_score_gemma":4.3608532e-7,"teacher_disagreement_score":0.9822213,"about_ca_system_score_codex":0.000032511904,"about_ca_system_score_gemma":0.0000040520254,"threshold_uncertainty_score":0.5397057},"labels":[],"label_agreement":null},{"id":"W2888578229","doi":"10.15420/ecr.2006.0.2.1i","title":"Cardiovascular Magnetic Resonance for the Inter ventional Cardiologist","year":2006,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal Heart Institute","funders":"","keywords":"Magnetic resonance imaging; Cardiac magnetic resonance; Medicine; Cardiology; Internal medicine; Radiology","score_opus":0.02914985752023159,"score_gpt":0.30409337565491584,"score_spread":0.27494351813468426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888578229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034234312,0.81549925,0.15306416,0.0018053821,0.000095682255,0.0014273707,0.00003386949,0.00010904789,0.027930982],"genre_scores_gemma":[0.110194944,0.8280276,0.031195967,0.01037396,0.0058844783,0.0028853498,0.0005490879,0.0002163151,0.010672293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988851,0.000197738,0.00030462773,0.00031597426,0.000091118054,0.00020546641],"domain_scores_gemma":[0.99893945,0.000103181825,0.000051258558,0.0007571699,0.00011619349,0.00003271856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008916582,0.00014105687,0.0005436931,0.000017489077,0.0001235336,0.0000050509875,0.0001755206,0.00003408612,0.000019120791],"category_scores_gemma":[0.00009727949,0.00008947768,0.00093124516,0.000111856636,0.00020744263,0.000015969845,0.000066273635,0.00015873641,0.000084049905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038448597,0.000032818876,0.0024005866,0.00075402664,0.0002110929,0.00012709775,0.0000034622433,0.00020089053,0.000102570586,0.008886099,0.40013215,0.58711076],"study_design_scores_gemma":[0.0002537283,0.00008091,0.023353383,0.00038968216,0.0005447814,0.0004940137,0.000001835515,0.000009677894,0.0000070003102,0.00020755336,0.97456443,0.00009301543],"about_ca_topic_score_codex":0.000003891212,"about_ca_topic_score_gemma":3.2348893e-7,"teacher_disagreement_score":0.5870177,"about_ca_system_score_codex":0.000029372402,"about_ca_system_score_gemma":0.000018854955,"threshold_uncertainty_score":0.3648794},"labels":[],"label_agreement":null},{"id":"W2888657924","doi":"10.15420/ecr.2014.9.2.92","title":"Echocardiographic Evaluation of Aortic Stenosis – Normal Flow and Low Flow Scenarios","year":2014,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Asymptomatic; Medicine; Stenosis; Cardiology; Hemodynamics; Internal medicine; Pressure gradient; Risk stratification; Radiology","score_opus":0.04407961671442465,"score_gpt":0.37068785853572567,"score_spread":0.326608241821301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888657924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007548846,0.9899233,0.00002240598,0.000019817377,0.00039553814,0.003314662,0.00018554842,0.000051180225,0.006012056],"genre_scores_gemma":[0.00072741386,0.99697036,0.000090832036,0.00023185083,0.00051541906,0.00020268746,0.0010912421,0.00013483578,0.000035351866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99227047,0.004626763,0.0012733793,0.00083223946,0.0005988531,0.0003982943],"domain_scores_gemma":[0.99717253,0.0001597388,0.0006274855,0.001283312,0.00044982613,0.00030711226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035576003,0.00070137443,0.0064128432,0.0002788669,0.00007522409,0.000013987477,0.00018495937,0.00019729216,0.000072557676],"category_scores_gemma":[0.0004961458,0.00051279896,0.0073512313,0.00047446354,0.00019935255,0.000043290045,0.00017714668,0.00039414535,0.00027217285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075821667,0.000033425647,0.0017237398,0.10265317,0.005659907,0.000049778035,0.0000038102103,0.0000073099986,3.411976e-8,0.0000010971042,0.0015609358,0.8882992],"study_design_scores_gemma":[0.0013005482,0.00027553184,0.011064291,0.14553979,0.1607901,0.00039140758,0.0000018936322,0.00007868366,2.4613055e-8,0.0000023850857,0.68006027,0.00049505034],"about_ca_topic_score_codex":0.0000023289947,"about_ca_topic_score_gemma":7.2257635e-8,"teacher_disagreement_score":0.88780415,"about_ca_system_score_codex":0.00009989418,"about_ca_system_score_gemma":0.00029850562,"threshold_uncertainty_score":0.9997324},"labels":[],"label_agreement":null},{"id":"W2943872206","doi":"10.15420/ecr.2018.26.1","title":"Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence","year":2019,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; Gilead Sciences; AstraZeneca; Amgen","keywords":"Medicine; Nice; Excellence; Angina; Coronary artery disease; Intensive care medicine; Medical therapy; Health care; Canadian Cardiovascular Society; Stable angina; Aspirin; Clinical trial; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.1930427198529203,"score_gpt":0.4462314850516187,"score_spread":0.2531887651986984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943872206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.0966719e-7,0.98044544,0.0012134473,0.008842738,0.0004861057,0.0028415772,0.0010149014,0.000028499868,0.005127095],"genre_scores_gemma":[0.0000013285126,0.9743807,0.0033193266,0.019309597,0.0013501026,0.00007719135,0.0014237448,0.000081006,0.00005703184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99343973,0.002775969,0.0021651469,0.0007568631,0.0005114019,0.00035090302],"domain_scores_gemma":[0.9953827,0.0014582606,0.00063149433,0.00083999697,0.001468014,0.00021951964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0076606045,0.0005122162,0.005133164,0.000054910004,0.00009553962,0.000008735118,0.00038891088,0.00012143843,0.000008911816],"category_scores_gemma":[0.006201316,0.00031637825,0.00148863,0.00020999531,0.0007009182,0.00003511909,0.00041920942,0.00042861796,0.0000122086085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004077589,0.00000495076,0.00005050431,0.2757709,0.0005997464,0.000024278255,0.000018892546,3.3298363e-7,1.9082512e-8,0.00008339968,0.29678744,0.42665544],"study_design_scores_gemma":[0.0003886171,0.00010379887,0.000049511622,0.3056034,0.0019500129,0.0003713962,0.000029211647,0.0000011413488,1.022987e-8,0.000005093076,0.69133747,0.00016035575],"about_ca_topic_score_codex":0.000011522879,"about_ca_topic_score_gemma":2.391853e-7,"teacher_disagreement_score":0.4264951,"about_ca_system_score_codex":0.00006162332,"about_ca_system_score_gemma":0.0008198277,"threshold_uncertainty_score":0.99992883},"labels":[],"label_agreement":null},{"id":"W2996052135","doi":"10.15420/ecr.2019.14.3.ge1","title":"Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?","year":2019,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Clopidogrel; CYP2C19; P2Y12; Pharmacology; Platelet; Drug; Cytochrome P450; Medicine; Internal medicine; Myocardial infarction; Metabolism","score_opus":0.10869964994137195,"score_gpt":0.31121510340031255,"score_spread":0.20251545345894062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996052135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044228585,0.9895166,0.000056844587,0.00016257909,0.00034863866,0.0056439186,0.0001319629,0.00006624079,0.00402897],"genre_scores_gemma":[0.00007796068,0.99818313,0.00002032913,0.00019454285,0.00066018256,0.0001257255,0.000108504,0.00019466066,0.00043494924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905868,0.0065148086,0.001050527,0.0009208964,0.00042941413,0.0004975468],"domain_scores_gemma":[0.99686,0.00038097907,0.0005594033,0.0019170303,0.00006860139,0.0002139557],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039808666,0.0008573326,0.007676278,0.00012458499,0.0000988192,0.000024984773,0.00069606263,0.00021749422,0.0001339232],"category_scores_gemma":[0.0002595613,0.00045175935,0.0055275587,0.00047805763,0.00020006247,0.000042901876,0.00027441714,0.00073854416,0.0008064616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003423639,0.000008245348,0.00002864074,0.25855285,0.0034874643,0.00033996013,0.000018894738,0.0000016860595,4.6220842e-7,0.0000072153134,0.006890401,0.7306299],"study_design_scores_gemma":[0.0006342582,0.00043541682,0.000026151469,0.13808335,0.014091141,0.00135393,0.000011230189,2.9931175e-7,7.485864e-7,1.4544732e-7,0.8450162,0.0003471361],"about_ca_topic_score_codex":9.733974e-7,"about_ca_topic_score_gemma":3.5340307e-8,"teacher_disagreement_score":0.83812577,"about_ca_system_score_codex":0.00007468153,"about_ca_system_score_gemma":0.00020844176,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W3015832087","doi":"10.15420/ecr.2019.04","title":"Interatrial Shunting for Treating Acute and Chronic Left Heart Failure","year":2020,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Shunting; Medical therapy; Heart failure; Cardiology; Left atrium; Shunt (medical); Refractory (planetary science); Internal medicine; Intensive care medicine; Atrial fibrillation","score_opus":0.036697307252288355,"score_gpt":0.3362243058753406,"score_spread":0.2995269986230522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015832087","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.832264e-7,0.9906377,0.00061492,0.00072740705,0.00029454316,0.0031026662,0.00006542755,0.00014706989,0.0044097914],"genre_scores_gemma":[0.0000068359263,0.9944182,0.0008027288,0.00049894734,0.003197801,0.00012559477,0.00064695324,0.00014550926,0.00015744184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966058,0.0011058707,0.00097092293,0.0008433752,0.00011738386,0.000356629],"domain_scores_gemma":[0.9983256,0.00029296477,0.00030408954,0.00077393826,0.00010329746,0.00020012633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010506259,0.00053144526,0.0050686616,0.00010052999,0.00015767098,0.0000391723,0.00020998821,0.00017807406,0.000026391124],"category_scores_gemma":[0.0006047343,0.000413799,0.003525619,0.00022710559,0.000090462854,0.000038267422,0.00026460667,0.00073465705,0.00028126594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000610252,0.0000043843315,0.0000064525548,0.06752501,0.0038506906,0.0001180176,0.000011083749,2.4975412e-7,0.000002402574,0.000051564464,0.032976955,0.8954471],"study_design_scores_gemma":[0.0006030732,0.00015983482,0.0000040271366,0.07192521,0.021502638,0.0068000215,0.0000016795337,0.0000021223773,1.2774092e-7,0.0000014384962,0.8987158,0.0002840262],"about_ca_topic_score_codex":5.308455e-7,"about_ca_topic_score_gemma":3.616681e-7,"teacher_disagreement_score":0.89516306,"about_ca_system_score_codex":0.000119276076,"about_ca_system_score_gemma":0.00026922522,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W3158223130","doi":"10.15420/ecr.2020.42","title":"Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project","year":2021,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pharmacotherapy; Family medicine; Medical prescription; Clinical Practice; Internal medicine; Nursing","score_opus":0.16051801254864836,"score_gpt":0.44463393479437935,"score_spread":0.284115922245731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158223130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.905841e-7,0.97302777,0.00012001362,0.00017635681,0.00025398337,0.005992395,0.00001476835,0.000010167694,0.020403532],"genre_scores_gemma":[0.0000028312343,0.9962267,0.0023178584,0.00037813254,0.00038444373,0.0001351355,0.00005590392,0.00005476103,0.0004441839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98383635,0.012919938,0.002092161,0.00056676957,0.00036333085,0.00022142056],"domain_scores_gemma":[0.9967658,0.00062234496,0.0010270282,0.0013288454,0.00019005033,0.00006596534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012828193,0.00031793563,0.004842207,0.000105423234,0.00003337566,0.00000441604,0.0002482547,0.000121627134,0.000012749183],"category_scores_gemma":[0.0009541083,0.00019157266,0.0015295452,0.00073540234,0.00018063954,0.000032572414,0.00035287667,0.00072814577,0.000011413265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009660597,0.00003924889,0.000058856156,0.15187404,0.001558737,0.00047645695,0.000007635784,9.517283e-7,3.73595e-8,0.00022654417,0.0033788434,0.84236896],"study_design_scores_gemma":[0.00036770213,0.000071282164,0.0006128204,0.14514732,0.0060755857,0.0005758629,0.000013305744,3.839712e-7,5.231862e-8,7.6010537e-7,0.84701806,0.000116864074],"about_ca_topic_score_codex":0.000012373581,"about_ca_topic_score_gemma":9.611537e-7,"teacher_disagreement_score":0.8436392,"about_ca_system_score_codex":0.00007498261,"about_ca_system_score_gemma":0.0006763678,"threshold_uncertainty_score":0.78121066},"labels":[],"label_agreement":null},{"id":"W3176740384","doi":"10.15420/ecr.2020.45","title":"2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome","year":2021,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Biosense Webster; Abbott Vascular; Regeneron Pharmaceuticals; Orient Europharma; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Daiichi Sankyo Europe; Sanofi; Servier; American College of Cardiology Foundation; Amgen; Pfizer","keywords":"Medicine; Antithrombotic; Asia pacific; Acute coronary syndrome; Intensive care medicine; Consensus conference; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.04115686427521839,"score_gpt":0.3160812144214424,"score_spread":0.27492435014622396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176740384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008685023,0.9885686,0.0004468486,0.00039758504,0.00081569236,0.004279222,0.00092542625,0.00009251198,0.0044654184],"genre_scores_gemma":[0.00017230901,0.9927341,0.0007666782,0.00033436858,0.0006546626,0.00028081614,0.004369258,0.00019929883,0.00048852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920962,0.0043970193,0.0014816911,0.0012050131,0.00025235242,0.0005677526],"domain_scores_gemma":[0.99665475,0.00038233274,0.0007956465,0.0017840283,0.000186571,0.0001967015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017767736,0.00081737357,0.008401359,0.00010908199,0.00019054898,0.00001058135,0.000372646,0.00030655443,0.00013124716],"category_scores_gemma":[0.00010950965,0.0006647229,0.0075166766,0.00045399784,0.00040088606,0.000019874133,0.00020552338,0.0007352757,0.00024727738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001588928,0.000037899175,0.000032352797,0.10875745,0.02153631,0.0021552378,0.000003695182,0.000008124745,8.968334e-8,0.00014348704,0.10877708,0.7585324],"study_design_scores_gemma":[0.0010369649,0.0006804001,0.00047154538,0.08274233,0.029243851,0.007817715,0.000031896565,3.595471e-7,6.3755984e-8,0.0000061794253,0.87751365,0.00045505105],"about_ca_topic_score_codex":7.1624146e-7,"about_ca_topic_score_gemma":9.815149e-8,"teacher_disagreement_score":0.76873654,"about_ca_system_score_codex":0.00022915367,"about_ca_system_score_gemma":0.00035946598,"threshold_uncertainty_score":0.9995804},"labels":[],"label_agreement":null},{"id":"W3209688304","doi":"10.15420/ecr.2021.22","title":"Women and Diabetes: Preventing Heart Disease in a New Era of Therapies","year":2021,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Cleveland Clinic; Idorsia Pharmaceuticals; Amarin Corporation; AstraZeneca; Bristol-Myers Squibb; CSL Behring; Duke Clinical Research Institute; HLS Therapeutics; Amgen; Eisai; American Heart Association","keywords":"Medicine; Type 2 diabetes; Heart failure; Disease; Intensive care medicine; Diabetes mellitus; Incretin; Aliskiren; Internal medicine; Endocrinology; Renin–angiotensin system; Blood pressure","score_opus":0.040374407731517445,"score_gpt":0.30805942109281587,"score_spread":0.2676850133612984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209688304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013721063,0.99564433,7.551154e-7,0.00024979288,0.00008164439,0.001604724,0.000010303408,0.000025806472,0.0022454348],"genre_scores_gemma":[0.000026723099,0.997293,0.000127605,0.0006792205,0.00016827282,0.00010023856,0.00014060609,0.00006416246,0.001400157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692345,0.001377629,0.0007517915,0.00049089204,0.00010881356,0.0003474281],"domain_scores_gemma":[0.99880946,0.00012078368,0.00025257596,0.00058918033,0.000027790074,0.00020022808],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008777292,0.000377655,0.0041979314,0.00009775488,0.000017530365,0.000009926125,0.00011891206,0.00004886031,0.0000723698],"category_scores_gemma":[0.00020148094,0.00027372828,0.00063006155,0.00027468064,0.00007260294,0.00003120348,0.00023901969,0.00029587676,0.00004859611],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016045183,0.00003034437,0.0023867534,0.12311073,0.0007986483,0.00024929966,0.000029578774,2.7745937e-8,8.227964e-8,0.000015817219,0.0033757442,0.8700014],"study_design_scores_gemma":[0.0002618627,0.00008264089,0.0012351546,0.18488415,0.0023579465,0.000013883615,0.0000037111672,5.3118484e-8,9.57745e-9,0.0000059983336,0.8110052,0.00014944821],"about_ca_topic_score_codex":8.703481e-7,"about_ca_topic_score_gemma":1.3167227e-7,"teacher_disagreement_score":0.86985195,"about_ca_system_score_codex":0.00006447349,"about_ca_system_score_gemma":0.00021587717,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W4200174855","doi":"10.15420/ecr.2021.49","title":"Why We Need Specialised Centres for Women’s Hearts: Changing the Face of Cardiovascular Care for Women","year":2021,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Disease; Gerontology; Face (sociological concept); Family medicine; Internal medicine","score_opus":0.10946852542074868,"score_gpt":0.36148348701145594,"score_spread":0.25201496159070724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200174855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013788944,0.985624,0.00023478162,0.0010030144,0.0012202169,0.009375383,0.00057427905,0.00006015057,0.0019067528],"genre_scores_gemma":[0.0000061774313,0.9897582,0.0000925564,0.0026424157,0.0032679185,0.0023597,0.00079973304,0.00021526514,0.0008580234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99282324,0.0033011376,0.0013806521,0.001040027,0.0003328296,0.0011221226],"domain_scores_gemma":[0.9959175,0.0006982202,0.00047831866,0.002082064,0.00055658905,0.00026731455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040351297,0.0007115663,0.008246026,0.00018877763,0.00022542721,0.000018938701,0.0005008654,0.00024131997,0.000062789906],"category_scores_gemma":[0.0009460208,0.00046649022,0.004864479,0.0005691311,0.00015000177,0.000025488813,0.00022712024,0.000501216,0.000024368888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001291168,0.0000075254643,0.0000014346434,0.3371408,0.0033764318,0.00006213955,0.0019450923,0.0000027757458,5.1832135e-8,0.0000218939,0.017051134,0.6403778],"study_design_scores_gemma":[0.0006023605,0.00023294173,0.0000014247227,0.06584358,0.0040213643,0.00035521248,0.0063475487,1.9665302e-7,2.760861e-7,0.0000035685125,0.9222527,0.00033879626],"about_ca_topic_score_codex":0.000002946394,"about_ca_topic_score_gemma":7.2495084e-7,"teacher_disagreement_score":0.9052016,"about_ca_system_score_codex":0.0004911355,"about_ca_system_score_gemma":0.0005054134,"threshold_uncertainty_score":0.9997787},"labels":[],"label_agreement":null},{"id":"W4225626385","doi":"10.15420/ecr.2021.38","title":"Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation","year":2022,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; BC Innovation Council; University of British Columbia","funders":"Biosense Webster; Servier; Boston Scientific Corporation; Pfizer","keywords":"Cryoablation; Medicine; Atrial fibrillation; Sinus rhythm; Catheter ablation; Guideline; Ablation; Quality of life (healthcare); Internal medicine; Digoxin; Cardiology; Intensive care medicine; Heart failure","score_opus":0.2988910814252262,"score_gpt":0.45254782064834126,"score_spread":0.15365673922311507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225626385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002092955,0.98778456,0.000058269135,0.00015545059,0.00087029324,0.0067075286,0.00009376639,0.0000643827,0.0042636297],"genre_scores_gemma":[0.000001991119,0.98757833,0.00017386903,0.00008010699,0.007299476,0.00002949178,0.0023599523,0.00009627161,0.0023804987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618655,0.0016873479,0.0012815304,0.0004511326,0.0001916662,0.00020175856],"domain_scores_gemma":[0.9975398,0.0008900243,0.0009208815,0.00052118656,0.000068689464,0.00005942207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010661193,0.0004170516,0.0039565833,0.00018286725,0.00009808458,0.000007684279,0.00011679042,0.00008172306,0.0006285326],"category_scores_gemma":[0.00035907383,0.00026367823,0.0034990178,0.00032083475,0.000048993632,0.000039533996,0.000057391735,0.00009307335,0.000065898246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002278729,0.0000022035172,0.00006378345,0.021404346,0.0011288113,0.000023826915,0.000014678733,0.0000054926954,3.611569e-8,0.00004137043,0.002877199,0.9742104],"study_design_scores_gemma":[0.0016037303,0.0009369417,0.000040548162,0.0056271413,0.0059082233,0.00008947903,0.000002887205,0.000001237384,7.0557626e-8,0.000003452626,0.9855725,0.00021376],"about_ca_topic_score_codex":0.000001437584,"about_ca_topic_score_gemma":1.7739929e-7,"teacher_disagreement_score":0.98269534,"about_ca_system_score_codex":0.00015654351,"about_ca_system_score_gemma":0.00022731983,"threshold_uncertainty_score":0.9999815},"labels":[],"label_agreement":null},{"id":"W4243879559","doi":"10.15420/ecr.2006.1.1h","title":"Physiological Responses to Percutaneous Coronary Intervention","year":2006,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"University of Southampton","keywords":"Thrombus; Cardiology; Medicine; Internal medicine; Percutaneous coronary intervention; Percutaneous; Occlusion; Coronary occlusion; Myocardial infarction","score_opus":0.036306234604210195,"score_gpt":0.31900032333953565,"score_spread":0.2826940887353255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243879559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7527986,0.16863531,0.0012524386,0.003807386,0.0005633858,0.0013703499,0.000060528022,0.0002938824,0.071218096],"genre_scores_gemma":[0.9798961,0.010961935,0.00038751558,0.003517126,0.00042845416,0.000019345764,0.00015236922,0.000026819347,0.0046103247],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99817616,0.00076958723,0.00043769917,0.00031570016,0.000092552924,0.00020831323],"domain_scores_gemma":[0.99925125,0.00010895548,0.00006380982,0.0003848298,0.00009502308,0.000096106334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049267337,0.00015746042,0.0005259377,0.000056174533,0.000055656474,0.0000064790966,0.00011597827,0.00003642057,0.0005215032],"category_scores_gemma":[0.00047822058,0.00012204471,0.0005092944,0.0001235155,0.000071892915,0.000020602482,0.00012879843,0.000158724,0.0020164615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078548066,0.00069589703,0.04611799,0.0028815367,0.00031153148,0.027089983,0.000020291069,0.000055536555,0.0059103565,0.0010701098,0.7692634,0.14579791],"study_design_scores_gemma":[0.00029853662,0.0012722964,0.59224266,0.0026626997,0.00024887177,0.011985582,0.000008636316,0.0000020858115,0.000005227371,0.00003268639,0.39109662,0.0001441212],"about_ca_topic_score_codex":0.000006371216,"about_ca_topic_score_gemma":0.0000011905704,"teacher_disagreement_score":0.54612464,"about_ca_system_score_codex":0.000043849162,"about_ca_system_score_gemma":0.000014393601,"threshold_uncertainty_score":0.9987606},"labels":[],"label_agreement":null},{"id":"W4313406139","doi":"10.15420/ecr.2022.33","title":"Under-representation of Women as Proceduralists and Patients in TAVR and TMVr Procedures: Data, Implications and Proposed Solutions","year":2022,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"Abbott Vascular; Monash University; Abiomed; Boston Scientific Corporation; Edwards Lifesciences; AstraZeneca","keywords":"Representation (politics); Psychological intervention; Medicine; Clinical trial; Valve replacement; Cardiology; Internal medicine; Political science; Nursing; Law","score_opus":0.10273663654786667,"score_gpt":0.42052922526956377,"score_spread":0.3177925887216971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313406139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020486044,0.9926077,9.354593e-7,0.00011406798,0.00003934328,0.0034232896,0.0005453208,0.000020358168,0.0012003868],"genre_scores_gemma":[0.0030547783,0.99280953,0.00001803964,0.00022621162,0.00004372871,0.00023933504,0.0035155655,0.00004979745,0.00004301522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973263,0.0008548885,0.0006678752,0.0007332548,0.00013575009,0.0002819015],"domain_scores_gemma":[0.99854374,0.00014040296,0.0003510498,0.0007123455,0.00006806659,0.00018441833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005124624,0.00031041383,0.002076053,0.00013849935,0.00010127858,0.000012214617,0.0001376359,0.000058712685,0.000018405206],"category_scores_gemma":[0.00059707306,0.00024518083,0.00031744802,0.00033459207,0.00018036157,0.00007506733,0.00056920154,0.00021037395,0.000008184603],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025931668,0.00019314863,0.036379542,0.13498689,0.001868409,0.00003955491,0.00011134904,1.5609439e-7,2.1647635e-7,0.00020870971,0.0015164702,0.8246696],"study_design_scores_gemma":[0.0011216376,0.0002776045,0.19855978,0.018982317,0.006610363,0.00056432094,0.00006986133,2.6597004e-7,9.824478e-9,0.000039053237,0.7734818,0.0002930057],"about_ca_topic_score_codex":0.000020014222,"about_ca_topic_score_gemma":0.0000019276242,"teacher_disagreement_score":0.82437664,"about_ca_system_score_codex":0.00014480199,"about_ca_system_score_gemma":0.00033946382,"threshold_uncertainty_score":0.9998183},"labels":[],"label_agreement":null},{"id":"W4385303023","doi":"10.15420/ecr.2023.04","title":"Ablation as First-line Therapy for Atrial Fibrillation","year":2023,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Stornoway Diamond (Canada); Centre for Social Innovation; Montreal Heart Institute; University of British Columbia","funders":"Biosense Webster","keywords":"Medicine; Catheter ablation; Atrial fibrillation; Sinus rhythm; Adverse effect; Ablation; Cardiology; Internal medicine; Ablation Therapy; Quality of life (healthcare); Intensive care medicine; Disease; Cancer","score_opus":0.2543860098426024,"score_gpt":0.43974050150045424,"score_spread":0.18535449165785184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385303023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.782542e-7,0.98424274,0.00024686128,0.0009816139,0.0011914021,0.0072855367,0.00004122569,0.0003010132,0.0057090484],"genre_scores_gemma":[7.549811e-7,0.9743526,0.0001091743,0.0003065415,0.016564298,0.000019483436,0.0025565256,0.0001950432,0.005895558],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659544,0.0008916358,0.0013551536,0.00063286285,0.00021372532,0.00031120662],"domain_scores_gemma":[0.99753135,0.00082492986,0.0007480943,0.00065480033,0.00014051187,0.00010028582],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021037294,0.0005093135,0.0038447895,0.00022432064,0.00013643524,0.000022360206,0.00017105958,0.0002050212,0.000101501],"category_scores_gemma":[0.0012710553,0.00036928072,0.0038195525,0.0005114803,0.000047467343,0.000055143715,0.00010024244,0.000208263,0.0032332826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046235997,4.3975095e-7,0.000065915505,0.054392558,0.0010770379,0.0000281932,0.0000033033507,0.000012629767,1.8999573e-8,0.00015417501,0.013421579,0.93079793],"study_design_scores_gemma":[0.0008464734,0.00026775253,0.00010847956,0.032278985,0.0046674097,0.000092622206,5.758749e-7,0.000004008299,1.13557785e-8,0.00003420967,0.9613968,0.00030265594],"about_ca_topic_score_codex":9.638854e-7,"about_ca_topic_score_gemma":2.1967172e-7,"teacher_disagreement_score":0.9479752,"about_ca_system_score_codex":0.00008370273,"about_ca_system_score_gemma":0.00012651364,"threshold_uncertainty_score":0.9998759},"labels":[],"label_agreement":null},{"id":"W4405796048","doi":"10.15420/ecr.2024.41","title":"From Atrial Small-conductance Calcium-activated Potassium Channels to New Antiarrhythmics","year":2024,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Daiichi Sankyo Europe; Deutsche Forschungsgemeinschaft; ZonMw; European Society of Cardiology; European Commission","keywords":"Medicine; Potassium; Calcium; Conductance; Cardiology; Potassium channel; Calcium-activated potassium channel; Internal medicine; Pharmacology; Materials science","score_opus":0.0805442599774793,"score_gpt":0.3519022608410761,"score_spread":0.27135800086359685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405796048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025854648,0.9843619,0.00014558535,0.0010769876,0.0063854693,0.0033008743,0.00032367685,0.00038544432,0.0039942265],"genre_scores_gemma":[0.000004610201,0.9599305,0.0003573644,0.0026019767,0.031127209,0.0000642453,0.0014841922,0.0003777256,0.0040521915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925172,0.0026488055,0.0016528197,0.001969389,0.00023818159,0.0009736101],"domain_scores_gemma":[0.99660796,0.00029541535,0.0004926389,0.0017827852,0.00013699014,0.0006842298],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00096809847,0.0013680076,0.009171739,0.0002941109,0.00010919637,0.000043448534,0.0004997907,0.00061064895,0.00018249017],"category_scores_gemma":[0.0006396359,0.0010040302,0.0051214485,0.001111456,0.00016297346,0.000051534105,0.00053889956,0.0023943037,0.011123078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007166829,0.000008399965,2.6986336e-7,0.032299582,0.0041580056,0.01238913,0.000030601226,0.0000031182851,0.00006800977,0.000032383246,0.19760427,0.7533346],"study_design_scores_gemma":[0.00033390606,0.00024115399,0.0000019908923,0.092931524,0.016976377,0.0063214805,0.0000016623086,1.7289884e-7,0.000003831876,0.000025532956,0.8823949,0.00076748256],"about_ca_topic_score_codex":0.000021028023,"about_ca_topic_score_gemma":4.5101203e-7,"teacher_disagreement_score":0.75256705,"about_ca_system_score_codex":0.0002419354,"about_ca_system_score_gemma":0.0010294893,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W4405796076","doi":"10.15420/ecr.2024.24","title":"Cardiovascular Implications of Non-steroidal Anti-inflammatory Drugs: A Comprehensive Review, with Emphasis on Patients with Rheumatoid Arthritis","year":2024,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi; Pfizer; Women's College Hospital; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Disease; Intensive care medicine; Cyclooxygenase; Mechanism (biology); Arthritis; Pharmacology; Internal medicine","score_opus":0.01571146196190841,"score_gpt":0.27531640673557106,"score_spread":0.25960494477366264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405796076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022411623,0.98799866,0.000015349788,0.00006719846,0.0003472939,0.00742897,0.00023850186,0.00013791233,0.0035419671],"genre_scores_gemma":[0.00007593608,0.9967136,0.00006724514,0.0008891096,0.00036173142,0.00059863646,0.0008916887,0.00036507726,0.000037014714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99314094,0.002305246,0.0019049793,0.0013266874,0.00070545793,0.00061667257],"domain_scores_gemma":[0.9951108,0.00022479332,0.0009699147,0.0026888705,0.0006540208,0.0003516157],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014540169,0.0012815807,0.0104280915,0.00032979684,0.00011136923,0.000016603364,0.00046555328,0.00023053616,0.000028902601],"category_scores_gemma":[0.00013071754,0.00077096245,0.0031164617,0.0008064863,0.00040509162,0.000065817716,0.00019727446,0.001124419,0.0011003414],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018379054,0.000040540126,0.0002178217,0.39009756,0.004999809,0.00070735096,0.000018249282,7.407072e-7,1.3200618e-7,0.000006165833,0.014902313,0.5889909],"study_design_scores_gemma":[0.00065684074,0.00044640395,0.00069020514,0.4126099,0.008616828,0.0009320184,0.0000018514374,4.13683e-8,1.99704e-7,1.2268241e-7,0.575632,0.00041359116],"about_ca_topic_score_codex":0.0000015842287,"about_ca_topic_score_gemma":2.7715674e-7,"teacher_disagreement_score":0.58857733,"about_ca_system_score_codex":0.00015778946,"about_ca_system_score_gemma":0.00052578934,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W4414353240","doi":"10.15420/ecr.2025.28","title":"Left Main Disease: The Last Frontier for Medical Therapy in Stable Coronary Artery Disease?","year":2025,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Coronary artery disease; Randomized controlled trial; Clinical trial; Disease; Stenosis; Clinical Practice; Medical therapy; Arterial disease; Adverse effect","score_opus":0.03874506703259494,"score_gpt":0.34275617666685787,"score_spread":0.3040111096342629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414353240","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014163394,0.98796165,0.000331693,0.0017374479,0.00081839296,0.0045468262,0.000678255,0.00004887724,0.0038754179],"genre_scores_gemma":[0.000009182049,0.9883864,0.000032192536,0.003868074,0.0006918679,0.00055209064,0.0017808757,0.00008805569,0.0045912685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99476653,0.0025657092,0.0012411482,0.0006851501,0.00027918,0.00046226854],"domain_scores_gemma":[0.9967004,0.0013683889,0.00023163077,0.0012313662,0.00008738453,0.0003808242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021659352,0.0005377244,0.0030200484,0.00013992308,0.00010244623,0.000017643442,0.0005875721,0.00012930618,0.0006540731],"category_scores_gemma":[0.002104334,0.0003197137,0.0022596885,0.00022860408,0.00021762059,0.00003317159,0.0002638899,0.00067226985,0.00020179058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046683566,0.00009619409,0.00074962614,0.06616813,0.00042525795,0.00250852,0.0000023787438,2.6326245e-7,1.922944e-9,0.00009854997,0.1915512,0.7383532],"study_design_scores_gemma":[0.0005299669,0.000112361005,0.0049972893,0.1763096,0.00253168,0.00045040745,0.00000255038,0.0000013323155,5.772812e-10,0.000025938169,0.8148197,0.00021916277],"about_ca_topic_score_codex":8.7149954e-7,"about_ca_topic_score_gemma":0.0000050459753,"teacher_disagreement_score":0.738134,"about_ca_system_score_codex":0.00011815644,"about_ca_system_score_gemma":0.0011653741,"threshold_uncertainty_score":0.9999255},"labels":[],"label_agreement":null}]}